Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-20-039101
Filing Date
2020-02-18
Accepted
2020-02-18 06:19:10
Documents
2
Group Members
MICHAEL ROBERT STEEDPALADIN CAPITAL CYBER GROUP, LLCPALADIN CAPITAL GROUP III, LLCPALADIN CYBER HOLDINGS, L.P.PALADIN HOLDINGS III (CAYMAN ISLANDS), L.P.PALADIN HOLDINGS III, L.P.PALADIN HOMELAND SECURITY CORP III, LTD.PALADIN III (CA), LPPALADIN III (CAY

Document Format Files

Seq Description Document Type Size
1 SC 13G d856986dsc13g.htm SC 13G 291079
2 EX-99.1 d856986dex991.htm EX-99.1 20853
  Complete submission text file 0001193125-20-039101.txt   314145
Mailing Address 6230 STONERIDGE MALL ROAD PLEASANTON CA 94588
Business Address 6230 STONERIDGE MALL ROAD PLEASANTON CA 94588 (925) 401-7300
10x Genomics, Inc. (Subject) CIK: 0001770787 (see all company filings)

EIN.: 455614458 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91164 | Film No.: 20623271
SIC: 3826 Laboratory Analytical Instruments

Mailing Address 2020 K STREET, NW SUITE 620 WASHINGTON DC 20006
Business Address 2020 K STREET, NW SUITE 620 WASHINGTON DC 20006 202-293-5590
Paladin Capital Management, LLC (Filed by) CIK: 0001788497 (see all company filings)

EIN.: 522306752 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G